Dr. David Aaron Mittleman, MD

Dr. Mittleman practices at Flagler Eye Surgery Center in West Palm Beach, Florida.

Dr. Mittleman's NPI, 1508818345, was assigned on May 17, 2006. Dr. Mittleman graduated from The Johns Hopkins University School of Medicine in 1988. Dr. Mittleman holds Florida license ME0062325.

Dr. Mittleman's primary practice is Flagler Eye Surgery Center, at 2000 Palm Beach Lakes Blvd Ste 301, West Palm Beach, FL 33409. The practice phone is (561) 500-2020.

Dr. Mittleman's primary practice is Flagler Eye Surgery Center in West Palm Beach, Florida. Dmand AI also links Dr. Mittleman to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mittleman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mittleman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mittleman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Mittleman's licenses on file in 3 states: Florida, New Jersey and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Mittleman treats.

CMS data shows 7,432 Medicare services from Dr. Mittleman across 24 procedure codes in 2024, for 1,679 Medicare patients. Medicare paid $742,286 for them.

CMS counts 1,679 Medicare patients who saw Dr. Mittleman in 2024. The largest group is 75 to 84, with 764 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mittleman's median patient age at 72, with 60% women.

In 2024, Dr. Mittleman wrote 1,976 Medicare Part D claims for 530 patients. 44% of them were for generic drugs. CMS names the drug for 1,882 of them, across 27 drugs with 11 or more claims each, at $485,046 in total drug cost. In 2023, CMS named 2,068 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mittleman for performance year 2024, reported as part of a group. Dr. Mittleman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 549 procedures of cataract surgery by Dr. Mittleman, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Mittleman. Dr. Mittleman's most frequent co-authors are Harvey Lee Carter, MD, James A. Davies, MD and Gregg A. Feinerman, MD.

CMS Open Payments shows 702 general payments to Dr. Mittleman from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Alcon Laboratories Inc paid the most, $25,655.

Dmand AI lists 2 awards for Dr. Mittleman, most recently CMS Stage 1 EHR in 2013.

Dr. Mittleman graduated from The Johns Hopkins University School of Medicine in 1988. Dr. Mittleman is a member of AAO.

Dr. Mittleman is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.